Promising leukemia drug trial pulled before it even started
NCT ID NCT06522373
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 22 times
Summary
This study was designed to test the safety of a new drug called MT-0169 in people with acute leukemia (AML or T-ALL) that has come back or not gone away with standard treatment. The drug targets a protein called CD38 found on leukemia cells. However, the trial was withdrawn before any patients were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.